You just read:

Allergan Reports Strong First Quarter 2016 Continuing Operations Performance with 48% Increase in Net Revenue to $3.8 Billion and 15% Growth in Non-GAAP Diluted EPS to $3.04

News provided by

Allergan plc

May 10, 2016, 07:30 ET